The role of patient advocacy/parent support groups

South African Medical Journal

Volumn 103, Issue SUPPL. 1, 2013, Pages 1020-1022

  Hall, J G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Advocacy; Clinical genetic services; Festschrift; Genetic counselling; Human genetics; Rare genetic disorders; Trefor Jenkins

Indexed keywords

ARTICLE; FAMILY INTERACTION; FAMILY RELATION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; MEDICAL CARE; MONEY; NEWBORN SCREENING; PARENT SUPPORT GROUP; PATIENT ADVOCACY; RESEARCH; SCIENTIST; SOCIAL NETWORK; SOCIAL SUPPORT; SUPPORT GROUP;

CONSUMER ADVOCACY; GENETIC COUNSELING; HUMANS; PARENTS; PATIENT ADVOCACY;

EID: 84889686045     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.6976     Document Type: Article

References (30)

1. Jenkins T. Medical genetics in South Africa. J Med Genet 1990; 27(12): 760-779. [http://dx. doi. org/10. 1136/jmg. 27. 12. 760].
2. Genetic Alliance. Genetic Alliance Disease InfoSearch Inclusion Guidelines. http://www. geneticalliance. org/diseaseinfosearch (accessed 30 May 2012).
3. Unique-The Rare Chromosome Disorder Support Group. http://www. rarechromo. org/html/home. asp (accessed 30 May 2012).
4. International Alliance of Patients' Organizations. Membership Guide. http://www. patientsorganizations. org/iapoμmedia/Membership%20Guide%20Cover. jpg (accessed 30 May 2012).
5. Terry SF, Horn EJ, Scott J, Terry PF. Genetic alliance registry and biobank: A novel disease advocacy-driven research solution. Per Med 2008; 8(2): 207-213. [http://dx. doi. org/10. 2217/pme. 11. 1].
6. Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet 2008; 371(9629): 2039-2041. [http://dx. doi. org/10. 1016/S0140-6736(08)60872-7].
7. Gahl WA, Markello TC, Toro C, et al. The National Institutes of Health Undiagnosed Diseases Program: Insights into rare diseases. Genet Med 2012; 14(1): 51-59. [http://dx. doi. org/10. 1038/gim. 0b013e318232a005].
8. Knight AW, Senior TP. The common problem of rare disease in general practice. Med J Aust 2006; 185(2): 82-83.
9. Dunkle M, Pines W, Saltonstall PL. Advocacy groups and their role in rare diseases research. Adv Exp Med Biol 2010; 686: 515-525. [http://dx. doi. org/10. 1007/978-90-481-9485-8_28].
10. Ingelfinger JR, Drazen JM. Patient organizations and research on rare diseases. N Engl J Med 2011; 364(17): 1670-1671. [http://dx. doi. org/10. 1056/NEJMe1102290].
11. Sharp RR, Landy DC. The financing of clinical genetics research by disease advocacy organizations: A review of funding disclosures in biomedical journals. Am J Med Genet A 2010; 152A(12): 3051-3056. [http://dx. doi. org/10. 1002/ajmg. a. 33767].
12. Landy DC, Brinich MA, Colten ME, Horn EJ, Terry SF, Sharp RR. How disease advocacy organizations participate in clinical research: A survey of genetic organizations. Genet Med 2012; 14(2): 223-228. [http://dx. doi. org/10. 1038/gim. 0b013e3182310ba0].
13. Lyon GJ. Personalized medicine: Bring clinical standards to human-genetics research. Nature 2012; 482(7385): 300-301. [http://dx. doi. org/10. 1038/482300a].
14. Vincent C, Davis R. Patients and families as safety experts. CMAJ 2012; 184(1): 15-16. [http://dx. doi. org/10. 1503/cmaj. 111311].
15. Lin AE, Terry SF, Lerner B, Anderson R, Irons M. Participation by clinical geneticists in genetic advocacy groups. Am J Med Genet A 2003; 119A(1): 89-92. [http://dx. doi. org/10. 1002/ajmg. a. 20027].
16. Clarke A. Confidentiality and serious harm in genetics. Eur J Hum Genet 2005; 13(4): 399. [http://dx. doi. org/10. 1038/sj. ejhg. 5201349].
17. Pyeritz RE. The family history: The first genetic test, and still useful after all those years? Genet Med 2012; 14(1): 3-9. [http://dx. doi. org/10. 1038/gim. 0b013e3182310bcf].
18. Biesecker BB. Goals of genetic counseling. Clin Genet 2001; 60(5): 323-330. [http://dx. doi. org/10. 1034/j. 1399-0004. 2001. 600501. x].
19. Wolf SM, Crock BN, Van Ness B, et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012; 14(4): 361-384. [http://dx. doi. org/10. 1038/gim. 2012. 23].
20. Falk MJ, Dugan RB, O'Riordan MA, Matthews AL, Robin NH. Medical geneticists' duty to warn at-risk relatives for genetic disease. Am J Med Genet A 2003; 120A(3): 374-380. [http://dx. doi. org/10. 1002/ajmg. a. 20227].
21. Hunter AG, Sharpe N, Mullen M, Meschino WS. Ethical, legal, and practical concerns about recontacting patients to inform them of new information: The case in medical genetics. Am J Med Genet 2001; 103(4): 265-276. [http://dx. doi. org/10. 1002/ajmg. 1568. abs].
22. Esmer C, Urraca N, Carnevale A, Del Castillo V. Patient follow-up is a major problem at genetics clinics. Am J Med Genet A 2004; 125A(2): 162-166. [http://dx. doi. org/10. 1002/ajmg. a. 20303].
23. Al-Kassimi M. Cultural differences: Practising medicine in an Islamic country. Clin Med 2003; 3(1): 52-53. [http://dx. doi. org/10. 7861/clinmedicine. 3-1-52].
24. Zlotogora J. Knowing the ethnic origin of the patient is important in making a diagnosis. Am J Med Genet 1998; 78(4): 393-394. [http://dx. doi. org/10. 1002/(SICI)1096-8628(19980724)78: 4<393:: AIDAJMG23> 3. 0. CO; 2-C].
25. Bittles A. Consanguinity and its relevance to clinical genetics. Clin Genet 2001; 60(2): 89-98. [http://dx. doi. org/10. 1034/j. 1399-0004. 2001. 600201. x].
26. Weaver DD, Baker D, Theobald M, et al. Minimum guidelines for the delivery of clinical genetics services. The Evaluation of Clinical Services Subcommittee, Great Lakes Regional Genetics Group. Am J Hum Genet 1993; 53(1): 287-289.
27. Hoffman A. The newborn screening translational research network. The ACMG Medical Geneticist 2011; Summer: 6-7.
28. CCMG Ethics and Public Policy Committee, Nelson TN, Armstrong L, et al. CCMG statement on direct-toconsumer genetic testing. Clin Genet 2012; 81(1): 1-3. [http://dx. doi. org/10. 1111/j. 1399-0004. 2011. 01789. x].
29. Gollust SE, Wilfond BS, Hull SC. Direct-to-consumer sales of genetic services on the Internet. Genet Med 2003; 5(4): 332-337. [http://dx. doi. org/10. 1097/01. GIM. 0000076972. 83711. 48].
30. Biesecker LG. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: Lessons from the ClinSeq project. Genet Med 2012; 14(4): 393-398. [http://dx. doi. org/10. 1038/gim. 2011. 78].